ESMC · Escalon Medical Corp
$0.18
+0.01 (+7.65%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— cleared Oct 13, 2026
The latest filing states the doubt was alleviated.
“Management's assessment was further supported by several favorable developments during the year, including the resolution of the Company's prior going concern uncertainty and its return to a cumulative pre-tax income position.”View the 10-K filed Oct 13, 2026
Market Cap
$1.36M
Shares
7.42M
Volume · Oct 19
5800
Avg daily vol (3M)
13.87K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.18
Open$0.18
Day$0.18–0.18
52W close$0.14–0.26
Avg vol 30d16K
Short int83K · 1.1% float · 4.4d
Short vol91%
DataJan 2020–Oct 2026
Filing10-K · Oct 13
Up next
filed Oct 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$12.74M
Trailing 12 months
Net income (TTM)
$4.01M
Trailing 12 months
Revenue growth YoY
+50.2%
Year over year
Operating margin
0.4%
Trailing 12 months
P / E (TTM)
0.6
Trailing earnings · reciprocal yield 158.8%
FCF yield
-30.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.4%
Year over year · more shares
Price change (1Y)
+6.3%
Trailing year
Short interest
1.1%
Latest settlement · 4.4 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−19%
below
Price vs 50-day avg
+3%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
36%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
+14%
trailing
YTD return
+8%
this year
Relative strength
+7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
1.12% of float · ▬ 0.0% MoM · 4.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
Free cash flow
$-407.0K
Quant / Vol
risk profile
Volatility
221%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−19%
Bearish
Price vs 50-day avg
+3%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
36%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
1.12% of float · ▬ 0.0% MoM · 4.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $0
Now $0 · 36%
Range high $0
vs 200-day avg -19%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ESMC
this stock
Escalon Medical Corp
|
$1.36M | +7.6% | -2.4% | 0.7 | 1.1% |
|
ABT
Abbott Laboratories
|
$179.20B | -16.9% | +5.7% | 33.3 | 0.8% |
|
MDT
Medtronic plc
|
$118.67B | -3.4% | +8.4% | 22.9 | 3.1% |
|
SYK
Stryker Corp
|
$114.28B | -15.2% | +11.2% | 30.9 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.16B | -52.8% | +12.5% | 18.2 | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
1
- % held
- 0.0%
- Net QoQ
- +1.3K sh
- Top holder
- VICTORY CAPITAL MANAGEMEN…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ESMC | +21.9% | +10.9% | +14.4% | +4.6% | +7.7% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | +23.4% | +11.8% | +6.7% | +4.1% | -4.8% |